Nalaganje...
FDA Finalizes Drug Communication Guidance: P&T Committees Can Receive Data Beyond the Drug Label
The FDA has made it easier for P&T committees to make formulary coverage decisions by expanding the health care economics information that drug manufacturers can provide to them.
Shranjeno v:
| izdano v: | P T |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MediMedia USA, Inc.
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6152691/ https://ncbi.nlm.nih.gov/pubmed/30271100 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|